Budecort Inhaler

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

92 API Suppliers, 26 USDMF, 28 CEP/COS, 7 JDMF, 8 EU WC, 16 KDMF, 37 NDC API, 47 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

150 Drugs in Development

150 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1155 FDF Dossiers, 54 FDA Orange Book, 966 Europe, 23 Canada, 18 Australia, 39 South Africa, 55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 13 DKSH, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives, 53 Fillers, Diluents & Binders, 42 Thickeners and Stabilizers, 35 Controlled & Modified Release, 25 Solubilizers, 23 Granulation, 23 Direct Compression, 20 Taste Masking, 20 Parenteral, 20 Film Formers & Plasticizers, 19 Topical, 18 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 140 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 186 Regulatory FDF Prices, 51 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

39 US Patents, 4 US Exclusivities, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 21 USP, 15 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21929 / DOSAGE - AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X)	BUDESONIDE	160ug
FORMOTEROL FUMARATE(UNII: W34SHF8J2K) (FORMOTEROL - UNII:5ZZ84GCW8B)	FORMOTEROL	4.5ug

Inactive Ingredients

Ingredient Name	REMEDYREPACK INC.
APAFLURANE(R40P36GDK6)
POLYETHYLENE GLYCOL 1000(U076Q6Q621)
POVIDONE K25(K0KQV10C35)

Setid 82af8b74 1f15 4a6d Bc7d 349b02732d29 Applno 21929 Form Aerosol Metered Inhalation Dosage 0 08mg Inh 0 0045mg Inh - Drug Product Composition: Budecort Inhaler